Company / Working Capital per Share
Jazz Pharmaceuticals Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$31.73
FY2025
5-year range
$27.14 / $57.67
FY2021-FY2025
Trend
-45.0%
vs FY2024
Sector context
#11 of 210
Health Care
What the data says
Among 210 Health Care companies, Jazz Pharmaceuticals is in the top 5% for working capital per share. Working Capital per Share has fluctuated over the past 10 years, ranging from $8.00 in FY2016 to $57.67 in FY2024.
Based on SEC 10-K filings.
31.73 in FY2025 with a 5-year CAGR of -4.0%. Top quartile in the Health Care sector.
Improved from $30.04 to $31.73 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Sector benchmark
-73.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 45.0% year-over-year.
- Ranks #11 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2024.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.73 | -45.0% |
| FY2024 | $57.67 | +92.0% |
| FY2023 | $30.04 | +10.7% |
| FY2022 | $27.14 | -15.4% |
| FY2021 | $32.08 | -17.6% |
| FY2020 | $38.94 | +77.5% |
| FY2019 | $21.94 | +45.4% |
| FY2018 | $15.09 | +33.8% |
| FY2017 | $11.27 | +40.8% |
| FY2016 | $8.00 | -52.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026